Académique Documents
Professionnel Documents
Culture Documents
Citizen
empowerment:
A megatrend
of the 21st century
Citizen
empowerment:
A megatrend
of the 21st century
Barcelona 26-28 May 2015 Hilton Diagonal Mar
Background
The AESGP Annual Meeting has been for decades the best attended and most
significant meeting of the consumer health industry. It brings together more than 400
delegates from all kind of stakeholder organisations and the industry. Major trends
for the sector are elaborated with leading experts in the field. In addition, the AESGP
Annual Meeting is a unique occasion to meet colleagues from the industry and relevant
organisations in the political and commercial environment.
Tuesday
26 May 2015
18.45 Buses leave the hotel Hilton Diagonal for transfer to the Opening event
19.15 Reception at the Casa Llotja de Mar, Passeig dIsabel II, 1, 08003
Barcelona
20.00
Welcome by
Roger Scarlett-Smith, AESGP President
Jordi Ramentol, President anefp, CEO Ferrer
Xavier Trias, Mayor of Barcelona
Wednesday
27 May 2015
14.00
09.00
This session will discuss the implications of new technologies and new media
on health information and citizens behaviour.
Brian McNamara, designated Head of Americas and Europe of the joint
GlaxoSmithKline and Novartis consumer health businesses
Sastry Chilukuri, Principal, McKinsey&Company
Stefan Bungart, Leader of Software and Analytics, General Electrics
Center of Excellence in Europe
Carlos Lens, Ministry of Health, Spain
12.30
Lunch | Networking
Numerous studies carried out over the last years show the economic and
social value of self-care. However, it is important to update or renew such
studies to be of best possible use. This session will present the results of
new work done on a pan-European level as well as in Spain and Greece.
Participants will get insight in new methodologies applied which should be
helpful for all kind of similar work in the future.
Anna Renner, Senior Researcher, Austrian Health Institute
Laura Pellis, Senior Researcher Center for Research in Health and
Economics (CRES) at the University Pompeu Fabra (UPF), Barcelona
Toni Gilabert, Director of Pharmacy Management and
Pharmacoeconomics, Catalonia Health Department
Nikos Maniadakis, Associate Dean, National School of Public Health,
Greece
15.30 Break | Networking
16.00
Thursday
28 May 2015
14.00
09.00
Over the last years, there has been an unprecedented increase in discussions
about safety issues on the European level, the so-called referral procedures.
Questions were raised if all these procedures were justified and if they
do not unnecessarily question existing products and hamper the move to
non-prescription status.
The session will also look at the intensive ongoing work in relation to the
implementation of the directive on falsified medicines with potentially
considerable implications in the marketplace.
Vincent Warnery, Senior Vice President, Global Consumer Healthcare
Division, Sanofi
June Raine, Chair of the Pharmacovigilance Risk Assessment Committee
(PRAC), EMA
Beln Escribano, Agency for Medicines and Health Products, Spain
Stefano Soro, European Commission
15.30
Break | Networking
16.00
The final session will allow leading health politicians to provide their perspective
on the future of citizen empowerment and self-care. Participants will get a
good understanding of the priorities of the new European Commission and
the new European Parliament in the given context.
Vytenis Andriukaitis, European Commissioner for Health and Food Safety
Peter Liese, Member of the European Parliament
Matthias Groote, Member of the European Parliament
These are key questions for many executives in the consumer health industry.
The session will follow up on the 2014 London conference and expose recent
positive developments and what needs to be done to keep the momentum.
17.30 Invitation to the 52nd AESGP Annual Meeting 31 May 2 June 2016 in the
Divani Apollon Hotel, Vouliagmeni, Athens, Greece
George Dokios, Executive Director, Association of the Greek Self-Care
Industry, EFEX
Albert Bourla, Group President; Vaccines, Oncology And Consumer
Healthcare Business, Pfizer
Erin Gainer, Chief Executive Officer, HRA Pharma
Darragh OLoughlin, President, Pharmaceutical Group of the
European Union (PGEU)
Andreas Pott, Acting Executive Director, European Medicines Agency (EMA)
Beln Crespo, Executive Director, Agency for Medicines and Health Products,
Spain
Practical
information
Simultaneous translation
The conference language is English.
Simultaneous translation will be
provided into Spanish.
Conference Venue
Hilton Diagonal Mar
Passeig del Taulat, 262-264
08019 Barcelona, Spain
Tel: +34 93 507 00 70
Fax: +34 93 507 00 78
Social programme
Participants and accompanying persons
are invited to attend the reception and
dinner at the Casa Llotja de Mar (Passeig
dIsabel II, 1, 08003 Barcelona)
on Tuesday, 26 May 2015 as
well as the closing dinner at the
Restaurant Barceloneta (Calle De
lEscar, 22, Moll dels Pescadors
Port Vell, 08039 Barcelona) on
Thursday, 28 May 2015.
Registration
The registration form for the meeting is
available at aesgp.eu/51 and should be
made no later than 30 April 2015.
Registration fees
Conference participants: 1.350 Euro
Accompanying family members:
300 Euro
Conference Secretariat
For all questions on participation and
registration, please contact AESGP.